Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03683420 · ClinicalTrials.gov registry record · NA

Music in Reducing Distress in Participants with Cancer During Chemotherapy Treatment

A NA study of Malignant Neoplasm and Caregiver, sponsored by Barbara Ann Karmanos Cancer Institute.

Completed
Registry status
NA
Development phase
1,000
Enrollment target
1
Study location

NCT03683420 is a NA study of Malignant Neoplasm and Caregiver that has completed, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 1,000 participants, above the 496-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (102% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03683420, a NA study of Malignant Neoplasm and Caregiver, has completed, sponsored by Barbara Ann Karmanos Cancer Institute.

COMPLETED
Registry status
NA
Development phase
1,000 participants
Enrollment target
1
Study location

Study Summary

This trial studies how well music works in reducing distress in participants with cancer during chemotherapy treatment. Music in participants receiving cancer treatment such as infusion treatment and caregiver may reduce pain, anxiety, and distress and improve participant's psychological and physiological wellbeing.

Interventions

  • BEHAVIORAL Music Therapy

Study Locations (1)

Michigan

  • Wayne State University/Karmanos Cancer Institute - Detroit

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2018-02-14
Est. Completion 2020-12-31
Phase NA

What the Registry Record Tells You About NCT03683420

The ClinicalTrials.gov registry entry for NCT03683420 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 496-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (102% higher). The listed sponsor is Barbara Ann Karmanos Cancer Institute, which has 139 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Malignant Neoplasm appearing as the primary indexed condition, and to 1 intervention - of which Music Therapy is the first listed.

NCT03683420 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT03683420 about?

NCT03683420 is a clinical study titled "Music in Reducing Distress in Participants with Cancer During Chemotherapy Treatment". This trial studies how well music works in reducing distress in participants with cancer during chemotherapy treatment. Music in participants receiving cancer treatment such as infusion treatment and caregiver may reduce pain, anxiety, and distress and improve participant's psychological and physiol...

What is the current status of trial NCT03683420?

This trial is currently completed. It is a NA study. The enrollment target is 1,000 participants. The study started on 2018-02-14. Estimated completion is 2020-12-31.

What conditions does trial NCT03683420 study?

This clinical trial studies the following conditions: Malignant Neoplasm, Caregiver.

What interventions are being tested in trial NCT03683420?

The interventions under investigation include: Music Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT03683420?

This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03683420 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malignant Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.